Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-27

Clinical Trial Update: Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Podofilox Topical Gel 0.5% to Condylox Gel 0.5% for external anogenital warts has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Condylox Gel 0.5% (podophyllin resin)
  • Podofilox topical gel 0.5% (podofilox)

Snippet

Sponsor: Dermax SA | Conditions: External Anogenital Warts | Phase 3 | Status: COMPLETED | Results posted: 2021-07-27